Spectricity raises €14m in Series B roun... Belgian semiconductor specialist Spectricity BV has baged €14m to speed up the development of mobile hyperspectral sensors for medical applications. more ➔
Sanofi snaps up mRNA partner for US$3.2bnSanofi further launches into the messenger RNA space with US$3.2bn buy-out of mRNA pioneer Translate Bio. more ➔
Abcam to acquire BioVision for $340mLife sciences tool provider Abcam plc has entered into a definitive agreement to acquire BioVision, Inc. for $340m. more ➔
Byondis and Glycotope merge platforms to t...Cancer and autoimmunity specialist Byondis BV and carbohydrate-targeting antibody company Glycotope have entered into a platform access agreement. more ➔
Artios Pharma Ltd raises US-$153m Series C...Cancer specialist Artios Pharma has raised $153m in a Series C Financing led by Omega Funds and TCG X to progress its clinical pipeline. more ➔
AXA IM Alts raises €1.9bn European Life...AXA IM Alts has raised €1.9bn of equity to accelerate investments into the Life Sciences sector. more ➔
Synaffix inks $246m deal with ProfoundBioSynaffix has nonexclusivey licensed its award-winning ADC technologies to Chinese ProfoundBio in an up to $246m deal more ➔
Panakès expands into biotech with €150m...Italian venture capital firm Panakès Partners, previously active in medtech, has closed the €150m purple fund with the goal to invest in underserved European Life Science companies. more ➔
BioNTech takes over cancer immunotherapy p...Mainz-based BioNTech is expanding its portfolio for cancer therapies with the neoantigen TCR Cell Therapy R&D pipeline and manufacturing site from Gilead Science subsidiary Kite Pharmaceuticals. more ➔
Nanosyrinx raises £6.2m to validate drug...Coventry-based NanoSyrinx plc has raised £6.2m in seed financing to develop a new cell engineering tool for novel targeted therapeutic modalities. more ➔
